Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in COLL — Collegium Pharmaceutical, Inc

CIK 1000275 TORONTO, A6
Back to COLL Full portfolio

Position in COLL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,393,698
+$452,791 QoQ
Shares Held
38,500
+35.3% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#97
of 280 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $624,876,791 across 66 Drug Manufacturers - Specialty & Generic names. COLL ranks #16 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RDY
Dr Reddys Laboratories Ltd
 9,213,269 $133,500,266
2 ZTS
Zoetis Inc.
 1,828,326 $131,383,499
3 NBIX
Neurocrine Biosciences Inc
 583,476 $98,339,041
4 BHC
Bausch Health Companies Inc.
 10,832,582 $53,404,627
5 VTRS
Viatris Inc
 3,135,460 $49,791,098
6 UTHR
UNITED THERAPEUTICS Corp
 62,600 $33,918,552
7 TEVA
Teva Pharmaceutical Industries Ltd
 953,413 $32,301,629
8 HLN
Haleon plc
 3,385,489 $31,586,609

All Filings in COLL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,393,698 38,500
2026-03-31 $940,907 28,452
2025-12-31 $1,327,326 28,668
2025-09-30 $1,808,700 51,692
2025-06-30 $1,514,691 51,224
2025-03-31 $1,749,506 58,610
2024-12-31 $2,744,124 95,781
2024-09-30 $2,724,349 70,506
2024-06-30 $1,451,188 45,068
2024-03-31 $1,919,066 49,435
2023-12-31 $1,568,916 50,972
2023-09-30 $966,637 43,250
2023-06-30 $875,308 40,731
2023-03-31 $753,812 31,422
2022-12-31 $499,749 21,541
2022-09-30 $298,355 18,624
2022-06-30 $271,026 15,295
2022-03-31 $299,312 14,701
2021-12-31 $121,326 6,495
2021-09-30 $71,991 3,647
2021-06-30 $73,520 3,110
2021-03-31 $16,590 700
2020-12-31 $26,840 1,340
2020-09-30 $47,886 2,300
2020-06-30 $144,812 8,275
2020-03-31 $212,600 13,019